PHI with Ankylosing spondylitis
How does this condition affect your private health insurance?
Bechterew's disease, officially known as Ankylosing Spondylitis (AS), is a chronic inflammatory autoimmune disease primarily affecting the spine. It causes inflammation of the vertebrae, leading to severe chronic pain and discomfort, particularly in the lower back and hips. Over time, in severe cases, the vertebrae can fuse, resulting in a rigid, immobile spine, often called a 'bamboo spine'. The disease can also affect other joints, eyes (uveitis), and, less commonly, the heart or lungs. It typically begins in early adulthood and progresses gradually, significantly impacting mobility and quality of life if not managed.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (gradual onset of symptoms)
Duration of Illness (Lifetime)
Chronic, lifelong disease
Cost of Treatment (Initial)
High (diagnosis, initial medication, physical therapy: hundreds to thousands of dollars)
Cost of Treatment (Lifetime)
Very high (ongoing medication, including biologics, physical therapy, regular medical evaluations: tens to hundreds of thousands of dollars, or more, depending on severity and medication)
Mortality Rate
Very low directly attributed to the disease itself, but slightly increased risk from complications (e.g., cardiovascular issues)
Risk of Secondary Damages
High (spinal fusion, severe kyphosis, uveitis, inflammatory bowel disease, cardiovascular complications, peripheral arthritis, reduced mobility, chronic pain)
Probability of Full Recovery
Extremely low/virtually none (it is a chronic, progressive condition; remission is the goal of treatment, not cure)
Underlying Disease Risk
Moderate (associated with other autoimmune conditions like Psoriasis, Inflammatory Bowel Disease (Crohn's disease or Ulcerative Colitis), and a genetic predisposition with HLA-B27 positivity)